Key Highlights
• Implantable medical devices are devices which can be implanted inside the body of the patient for the purpose of diagnosis of treatments. Many implants are prostheses used to replace missing body parts. Other implants may deliver medication, monitor physiological activity, or provide support to organs and tissues. The implants are either inserted permanently for diagnostic, monitoring, or therapeutic purposes, or they can be removed when no longer needed. Long-term implants benefit from being kept at a steady temperature, whereas adhesive joints have additional problems, such as complex loading conditions and ever-increasing device-lifetime requirements.
• The market size of the worldwide Active Implantable Medical Devices Industry surpassed USD XX billion in 2022, and by 2032, it is projected to reach USD XX billion, boosting at a CAGR of XX%.
• In August 2022, Medtronic plc has launched a new product for extravascular implantable cardioverter defibrillator (EV ICD) system defibrillator with the lead placed under the breastbone, outside of the heart and veins.
• The global expansion of the healthcare sector is fuelling the growth of the implantable medical device market. Active implantable medical devices are those that are designed to be completely or partially implanted into a patient's body. These devices are designed to be used in the human body for diagnostic or therapeutic purposes. The gadgets enter the human body either through a natural or surgical opening. The rising global incidence of cardiovascular illnesses is one of the primary reasons driving the growth of the implanted medical device market. Investments and money for the development of technologically improved goods, as well as favourable reimbursement scenarios for ENT operations in developed nations, drive market expansion. The rise in neurological illnesses and the expansion of neurostimulator applications both have an impact on the market.
Scope of the Industry Profile
Key Players
• Medtronic plc (Ireland)
• Abbott Laboratories (US)
• Boston Scientific Corporation (US)
• BIOTRONIK SE & Co. KG (Germany)
• LivaNova PLC (UK)
• Cochlear Limited (Australia)
• MED-EL (Austria)
• Sonova Holding AG (Switzerland)
• William Demant Holding A/S (Europe)
• Nurotron Biotechnology Co., Ltd. (China)
Segmentation
By Type
• Implantable Cardioverter Defibrillators
• Implantable Cardiac Pacemakers
• Ventricular Assist Devices
• Implantable Heart Monitors/Insertable Loop Recorders
• Implantable hearing devices
• Neurostimulators
By End User
• Hospitals
• Ambulatory Centers
• Cardiac Centers
• Dental Clinics
• Others
What to Expect from Industry Profile
1. Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the Active Implantable Medical Devices market in the world.
2. Use the PORTER’s Five Forces analysis to determine the competitive intensity and therefore market attractiveness of the Global Active Implantable Medical Devices market.
3. Leading company profiles reveal details of key Active Implantable Medical Devices market players’ global operations, strategies, financial performance & their recent developments.
4. Add weight to presentations and pitches by understanding the future growth prospects of the Global Active Implantable Medical Devices market with forecast for decade by both market share (%) & revenue (USD Million).
Recent Development
• In August 2022, Medtronic plc has launched a new product for extravascular implantable cardioverter defibrillator (EV ICD) system defibrillator with the lead placed under the breastbone, outside of the heart and veins.
• In February 2022, as part of its AVEIR DR i2i pivotal clinical research, Abbott began implanting a dual-chamber leadless pacemaker system in patients. The implantation of Abbott's investigational aveir dual-chamber leadless pacemaker is a key technological milestone for leadless pacing technology, and it is the first to occur globally within the pivotal trial.
Segment Insights
By Type
The increasing number of accidents resulting in bone and joint damage is fuelling the expansion of this market. Furthermore, the increasing prevalence of rheumatoid arthritis is fuelling the demand for elbow joint replacement surgeries. Rheumatoid arthritis affects approximately 458,000 Australians, according to the Australian Bureau of Statistics. In 2017-18. Furthermore, according to the Arthritis Report UK, 17.8 million people in the UK had a musculoskeletal ailment in 2018. As a result, the number of orthopaedic procedures is increasing, which may promote the growth of orthopaedic implants in the next years. During the projected period, the dentistry segment is expected to be the most opportune. This is mainly due to the increased demand for dental implants to improve the physical attractiveness of the face. According to the American Academy of Implant Dentistry (AAID), around 3 million Americans have dental implants, with the number predicted to increase by 500,000 every year. As a result, increased acceptance of dental implants is expected to boost market growth in the future years.
Regional Insights
In terms of revenue, North America dominated the global implanted medical devices market in 2021 and is expected to maintain its dominance during the forecast period. The increased frequency of numerous chronic diseases and the growing elderly population characterize North America. Furthermore, higher disposable income, the presence of improved healthcare infrastructure, the increasing use of minimally invasive surgeries, and rising consumer healthcare expenditure are the primary drivers projected to fuel the region's medical implants market expansion. Furthermore, the number of medical visits in the United States is increasing. According to the CDC, nearly 64% of the US population between the ages of 18 and 64 will visit medical health clinics in 2022. In the past, greater knowledge among the North American population about the availability of various medical implants has considerably contributed to market growth. Asia Pacific, on the other hand, is expected to be the most opportunistic market during the projection period. This is due to the growing geriatric population. According to the United Nations, almost 80% of the global elderly population is predicted to reside in low and middle-income countries. Furthermore, increased government and corporate investments in the construction of modern healthcare infrastructure in the region are expected to drive market expansion.
1 INTRODUCTION
1.1 Study Objectives
1.2 Market Definitions
1.2.1 Inclusions & Exclusions
1.2.2 Region: Inclusions & Exclusions
1.2.3 Study Scope
1.2.3.1 Markets Covered
1.2.3.2 Regional Scope
1.2.3.3 Years Considered
1.2.4 Currency Considered
1.2.5 Limitations
1.2.6 Summary Of Report (Chapter Wise Summary)
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary & Primary Research
2.1.2 Secondary Data
2.1.2.1 Secondary Sources
2.1.3 Primary Data
2.1.3.1 Primary Sources
2.2 Market Breakdown & Data Triangulation
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Research Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
3 EXECUTIVE SUMMARY
4 ACROSS THE GLOBE
4.1 Upcoming Attractive Market Opportunities
4.2 Country Wise Market Growth
4.3 Segment Wise Market Growth
5 MARKET OVERVIEW
5.1 Market Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.2 Restraints
5.2.3 Opportunities
5.2.4 Challenges
5.3 PORTOR’S Five Forces Analysis
5.3.1 Threat of New Entrants
5.3.2 Threat of Substitutes
5.3.3 Bargaining Power of Suppliers
5.3.4 Bargaining Power of Buyers
5.3.5 Intensity of Competitive Rivalry
5.4 Market Premium insights (Enterprise license)
5.4.1 Case Study Analysis
5.4.2 Country Wise Import & Export Data (If
Applicable)
5.4.3 Regulatory Bodies & Authorization
Across the Globe
5.4.4 Key Conferences & Events: 2022 &
2023
5.4.5 Top Patents for The Market: 2022
6 ACTIVE IMPLANTABLE MEDICAL DEVICES
MARKET OVERVIEW, BY END USER
6.1 Global Market Revenue & Share Analysis, By End User
6.1.1 Hospitals
6.1.2 Ambulatory Centers
6.1.3 Cardiac Centers
6.1.4 Dental Clinics
6.1.5 Others
6.2 Global Market Revenue & Share Analysis, 2018 – 2022
6.3 Global Market Revenue & Share Forecast Analysis, 2023 –
2032
6.4 Key Takeaways
7 ACTIVE IMPLANTABLE
MEDICAL DEVICES MARKET OVERVIEW, BY TYPE
7.1 Global Market Revenue & Share Analysis, By Type
7.1.1 Implantable Cardioverter Defibrillators
7.1.2 Implantable Cardiac Pacemakers
7.1.3 Ventricular Assist Devices
7.1.4 Implantable Heart Monitors/Insertable Loop
Recorders
7.1.5 Implantable hearing devices
7.1.6 Neurostimulators
7.2 Global Market Revenue & Share Analysis, 2018 – 2022
7.3 Global Market Revenue & Share Forecast Analysis, 2023 –
2032
7.4 Key Takeaways
8 ACTIVE IMPLANTABLE MEDICAL DEVICES
MARKET OVERVIEW, BY REGION
8.1 Global Market Revenue & Share Analysis, By Region
8.1.1 North America
8.1.2 Europe
8.1.3 Asia Pacific
8.1.4 Middle East & Africa
8.1.5 South America
8.2 Global Market Revenue & Share Analysis, 2018 – 2022
8.3 Global Market Revenue & Share Forecast Analysis, 2023 –
2032
8.4 Key Takeaways
9 NORTH AMERICA MARKET
ANALYSIS
9.1 North America Market Revenue & Share Analysis, By End
User
9.2 North America Market Revenue & Share Analysis, By Type
9.3 North America Market Revenue & Share Analysis, By
Country
9.3.1 US
9.3.2 Canada
9.3.3 Mexico
9.4 Key Takeaways
10 EUROPE MARKET ANALYSIS
10.1 Europe Market Revenue & Share Analysis, By End User
10.2 Europe Market Revenue & Share Analysis, By Type
10.3 Europe Market Revenue & Share Analysis, By Country
10.3.1 UK
10.3.2 Italy
10.3.3 Spain
10.3.4 Germany
10.3.5 France
10.3.6 Rest of Europe
10.4 Key Takeaways
11 ASIA PACIFIC MARKET ANALYSIS
11.1 APAC Market Revenue & Share Analysis, By End User
11.2 APAC Market Revenue & Share Analysis, By Type
11.3 APAC Market Revenue & Share Analysis, By Country
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Rest of APAC
11.4 Key Takeaways
12 MIDDLE EAST & AFRICA MARKET
ANALYSIS
12.1 MEA Market Revenue & Share Analysis, By End User
12.2 MEA Market Revenue & Share Analysis, By Type
12.3 MEA Market Revenue & Share Analysis, By Country
12.3.1 GCC
12.3.2 South Africa
12.3.3 Rest of MEA
12.4 Key Takeaways
13 SOUTH AMERICA MARKET ANALYSIS
13.1 SA Market Revenue & Share Analysis, By End User
13.2 SA Market Revenue & Share Analysis, By Type
13.3 SA Market Revenue & Share Analysis, By Country
13.3.1 Brazil
13.3.2 Argentina
13.3.3 Rest of SA
13.4 Key Takeaways
14 COMPETITIVE SCENARIO
14.1 Overview
14.2 Key Players Market Share Analysis
14.3 Recent Developments & Product Launches
14.4 Mergers & Acquisitions
14.5 Partnerships, Agreements & Collaborations
15 COMPANY PROFILES
15.1 Overview
15.2 Key players
15.2.1 Medtronic plc (Ireland)
15.2.1.1 Business Overview
15.2.1.2 Products Offered
15.2.1.3 Financial Insights
15.2.1.4 Strategic Developments
15.2.1.4.1 New Product Launches
15.2.1.4.2 Agreements & Collaborations
15.2.1.5 Business Aspects (NOISE Analysis)
15.2.1.5.1 Key Strengths
15.2.1.5.2 Opportunities
15.2.1.5.3 Weaknesses & Competitive Threats
15.2.1.5.4 Needs & Improvements
15.2.2 Abbott Laboratories (US)
15.2.3 Boston Scientific Corporation (US)
15.2.4 BIOTRONIK SE & Co. KG (Germany)
15.2.5 LivaNova PLC (UK)
15.2.6 Cochlear Limited (Australia)
15.2.7 MED-EL (Austria)
15.2.8 Sonova Holding AG (Switzerland)
15.2.9 William Demant Holding A/S (Europe)
15.2.10 Nurotron Biotechnology Co., Ltd. (China)
16 DISCLAIMER
17 APPENDIX
